🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The suppression of the immune system creates a permissive environment for d...
Status
Unknown
Location
Multiple Locations
Start Date
2017-08-05
Trial ID
NCT03214718
To test the efficacy of a combination chemotherapy of imatinib and 5-FU in ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2007-04
Trial ID
NCT01153750
Treatments Being Tested
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 ...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05
Trial ID
NCT02352558
Treatments Being Tested
In this phase I study, the investigators will determine the maximum tolerat...
Status
Completed
Location
Tennessee Oncology, PLLC
Start Date
2004-07
Trial ID
NCT00611689
Treatments Being Tested
This study evaluates the efficacy and safety of surgical intervention in pa...
Status
Unknown
Location
Multiple Locations
Start Date
2019-07
Trial ID
NCT03862768
Treatments Being Tested
The extension study followed the core study CAMN107ECN02 (NCT01275196). whi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-17
Trial ID
NCT02272777
Imatinib mesylate is an inhibitor of the receptor tyrosine kinases for plat...
Status
Completed
Location
Medical & Surgical Specialists, LLC
Start Date
2003-12
Trial ID
NCT00216112
Treatments Being Tested
This study investigates the safety, tolerability and dose equivalence of dr...
Status
Completed
Location
Celerion
Start Date
2022-12-16
Trial ID
NCT05623774
Treatments Being Tested
The objectives of Part 1 of the study were: * To determine the rate of hem...
Status
Completed
Location
Dana Faber Cancer Institute
Start Date
1999-08-09
Trial ID
NCT00171249
Treatments Being Tested